NDC 72288-033-00 - CLEARLAX

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
72288-033
Requested NDC
72288-033-00
Package NDCs from labels
72288-033-03, 72288-033-02, 72288-033-09, 72288-033-00, 72288-033-78
Manufacturer
Amazon.com Services LLC
Effective date
2026-09-08
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
CLEARLAX - Amazon.com Services LLCAmazon.com Services LLC2026-09-08HUMAN OTC DRUG LABEL

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 6 of 6 · 105 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Good Sense Clear LaxPOLYETHYLENE GLYCOL 3350Proficient Rx LP0858a914-4812-4e4d-82f8-ecf93d43ef3b2022-07-01WarningsExact identifier
application number: ANDA090685
unii: G2M7P15E5P
GAVILAXPOLYETHYLENE GLYCOL 3350Proficient Rx LP199d6173-3fad-49e4-88fe-bde7223ed4c32022-06-01WarningsExact identifier
rxcui: 876193
unii: G2M7P15E5P
Polyethylene GlycolPOLYETHYLENE GLYCOLBluePoint Laboratoriesc4cae70c-68da-0bbc-e053-2a95a90a395a2021-09-20WarningsExact identifier
unii: G2M7P15E5P
signature care clearlaxPOLYETHYLENE GLYCOL 3350Safeway91d2e780-2aae-411c-b7b3-820302f0f63e2021-05-13WarningsExact identifier
application number: ANDA090685
rxcui: 880407
rxcui: 876193
unii: G2M7P15E5P
POLYETHYLENE GLYCOL 3350 NFPOLYETHYLENE GLYCOL 3350SUNRISE PHARMACEUTICAL, INCce5197a1-2677-4ffb-aef2-9221b28ebd232020-01-22WarningsExact identifier
rxcui: 876193
unii: G2M7P15E5P

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.